Chinese Journal of Tissue Engineering Research ›› 2013, Vol. 17 ›› Issue (51): 8920-8927.doi: 10.3969/j.issn.2095-4344.2013.51.022

Previous Articles     Next Articles

Carotid artery stenting or carotid endarterectomy for treatment of carotid stenosis: Effectiveness and safety

Xin Hai, Bai Chao, Wang Yang, Li Xin-xi, Luo Jun, Tian Ye, Zhang Ke-rui   

  1. Department of Thyroid Surgery, First Affiliated Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
  • Online:2013-12-17 Published:2013-12-17
  • Contact: Luo Jun, Chief physician, Associate professor, Department of Thyroid Surgery, First Affiliated Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830054, Xinjiang Uygur Autonomous Region, China xmuluo@163.com
  • About author:Xin Hai★, Studying for master’s degree, Department of Thyroid Surgery, First Affiliated Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830054, Xinjiang Uygur Autonomous Region, China 115424316@qq.com

Abstract:

BACKGROUND: Large randomized trials have demonstrated carotid endarterectomy or stenting for symptomatic and asymptomatic extracranial carotid stenosis is effective.
OBJECTIVE: Using the meta analysis method, to evaluate efficacy and safety of carotid stenting and carotid endarterectomy for the treatment of carotid stenosis.
METHODS: Computer-based retrieval of databases both at home and abroad was performed for randomized controlled trials related to carotid stenting and carotid endarterectomy for the treatment of carotid stenosis. According to exclusion criteria, literature screening was done followed by quality evaluation. Then, the enrolled literatures were analyzed by Cochrane collaboration with RevMan5.0 Meta analysis software.
RESULTS AND CONCLUSION: There were 14 enrolled studies, including 7 693 patients among whom, 3 835 cases were in stenting group and 3 858 in carotid endarterectomy group. Compared with the carotid endarterectomy group, the stroke event rate within 30 days postoperatively, death and stroke event rate within 30 days postoperatively, myocardial infarction event rate within 1 year postoperatively and non-disabling stroke event rate within 30 days postoperatively were higher in the stenting group (P ≤0.000 1); the myocardial infarction event rate within 30 days postoperatively was lower in the stenting group (P=0.001 0). There were no significant differences in the death event rate and disabled stroke event rate within 30 days postoperatively between the two groups. These two treatments are complementary rather than antagonistic. We should optimize the treatment choice based on the comprehensive analysis of each patient's condition.


中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程


全文链接:

Key words: biocompatible materials, carotid stenosis, stents, endarterectomy, carotid

CLC Number: